STING1 and neoplasm: Preclinical research has shown that activation of the cGAS/STING pathway after DNA damage enhances immune cell infiltration into the tumor microenvironment (TME) through secretion of pro-inflammatory type I interferon (IFN) and induction of a senescence-associated secretory phenotype (SASP) [244].